Business Context and Reporting Period
This Form 8-K is a current report filed by ADVENTRX Pharmaceuticals, Inc. (not Savara Inc.) on June 28, 2011. The filing addresses Item 4.01, specifically the engagement of a new independent registered public accounting firm.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly procedural regarding the change in auditors and contains no financial performance data.
Material Changes
- Change in Certifying Accountant: On June 28, 2011, the Audit Committee engaged PricewaterhouseCoopers LLP (PwC) as the Company's new independent registered public accounting firm.
- Consultation History: The Company confirmed that neither it nor anyone on its behalf consulted with PwC regarding accounting principles, audit opinions, or reportable events during the years ended December 31, 2010 and 2009, or through June 28, 2011.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the standard disclosure regarding the auditor change.
Investor Verification Checklist
- Verify the identity of the registrant (ADVENTRX Pharmaceuticals, Inc.) versus the requested company name (Savara Inc.).
- Confirm the effective date of the engagement with PricewaterhouseCoopers LLP (June 28, 2011).
- Review subsequent filings to determine the reason for the auditor change, as this 8-K does not disclose the departure of the prior auditor.